Weighted Average Number of Shares Outstanding, Basic of TREACE MEDICAL CONCEPTS, INC. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Treace Medical Concepts, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to Q3 2025.
  • Treace Medical Concepts, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 63.5M shares, a 2.07% increase year-over-year.
  • Treace Medical Concepts, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 62.1M shares, a 2.07% increase from 2023.
  • Treace Medical Concepts, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60.9M shares, a 10.1% increase from 2022.
  • Treace Medical Concepts, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 55.3M shares, a 14.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

TREACE MEDICAL CONCEPTS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 63.5M +1.29M +2.07% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 63M +925K +1.49% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 62.7M +869K +1.41% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 62.1M +1.26M +2.07% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 62.2M +667K +1.08% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 62.1M +699K +1.14% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 61.8M +3.07M +5.23% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 60.9M +5.58M +10.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 61.6M +6.13M +11.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 61.4M +6.07M +11% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 58.7M +3.9M +7.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 55.3M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 55.4M +2.66M +5.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 55.3M +6.12M +12.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 54.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 52.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 49.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10

TREACE MEDICAL CONCEPTS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 62.1M +1.26M +2.07% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 60.9M +5.58M +10.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 55.3M +6.86M +14.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 48.4M +11.3M +30.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 37.1M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.